Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis. Obermann M, Ruck T, Pfeuffer S, Baum J, Wiendl H, Meuth SG Mult Scler. 2016 Mar 15. PMID: 26980848. Abstract CommentRecommendBookmarkWatch